Michigan vs Ohio Cannabis Laws

Michigan has emerged as one of the largest cannabis markets in the United States, with annual sales reaching approximately $3 billion at peak. Voters approved medical cannabis in 2008 through Proposition 1, and recreational legalization followed with Proposal 1 in November 2018. Recreational sales began in December 2019, and the market scaled rapidly due to Michigan's large population of 10 million and an open licensing framework.

The Michigan market is notable for its lack of license caps, which has led to a proliferation of retail locations and cultivation facilities. While this openness has benefited consumer access and driven down prices, it has also created significant oversupply challenges. Wholesale flower prices have declined dramatically, squeezing margins for cultivators and putting financial pressure on operators at every level of the supply chain. The state's caregiver system — which allows individuals to grow and supply cannabis to medical patients — adds additional supply outside the commercial market.

Despite the competitive pressures, Michigan remains a priority market for major MSOs including Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, Verano, TerrAscend, and Ayr Wellness. The 10% excise tax plus 6% sales tax keeps the combined rate moderate at 16%. Michigan's market dynamics serve as a cautionary example of how open licensing can lead to oversupply, but the state's large consumer base ensures it remains commercially significant.

Ohio became the 24th state to legalize recreational cannabis when voters approved Issue 2 in November 2023. As the seventh most populous state with 11.8 million residents, Ohio immediately became one of the most important cannabis markets in the country. Recreational sales launched in August 2024 through existing medical dispensaries, providing a relatively smooth transition from the medical program established in 2016.

The Ohio market's scale is significant. The medical program had already served over 300,000 registered patients, demonstrating strong demand even under medical-only access. With recreational legalization, the addressable market has expanded dramatically. Ohio's 10% excise tax rate is moderate and positions the legal market competitively. The state's central location in the Midwest, surrounded by states with less permissive cannabis laws (Indiana, Kentucky, West Virginia), drives additional cross-border demand.

Ohio is a priority market for all major MSOs. Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, Verano, TerrAscend, and Ayr Wellness all hold licenses in the state. The large population, strong existing medical infrastructure, and limited competition from neighboring states make Ohio one of the most anticipated growth markets in the US cannabis industry.